The present invention relates to novel human coagulation Factor VIIa variants having coagulant activity as well as polynucleotide constructs encoding such variants, vectors and host cells comprising and expressing the polynucleotide, pharmaceutical compositions, uses and methods of treatment.

 
Web www.patentalert.com

< Nucleic acid encoding DS-CAM proteins and products related thereto

< Spatially directed ejection of cells from a carrier fluid

> Gene therapy for cardiomyopathy

> Maspin transcriptional regulatory sequences and uses thereof
~ 00218